Compass Therapeutics
CMPX
CMPX
55 hedge funds and large institutions have $401M invested in Compass Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
45% more funds holding
Funds holding: 38 → 55 (+17)
3.47% less ownership
Funds ownership: 66.73% → 63.26% (-3.5%)
Holders
55
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$15.7M | |
| 2 | +$7.83M | |
| 3 | +$7.83M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.19M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.88M |
Top Sellers
| 1 | -$5.55M | |
| 2 | -$831K | |
| 3 | -$118K | |
| 4 |
Renaissance Technologies
New York
|
-$61.9K |
| 5 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$12.6K |